The search frequency for ABL Bio, a company known for developing biopharmaceuticals based on antibody therapeutics, has recently surged.

As of 1:30 PM on the 17th, ABL Bio's stock price is 31,350 KRW, down 5.57% from the previous day, with a trading volume of 4,832,396 shares, which is about 28.39% of the 5-day average trading volume. Today, foreigners have sold a net 134,000 shares of ABL Bio, while institutions have bought a net 2,000 shares, according to provisional data.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm's Listing... Discussing Technology Transfers with 15 Big Pharma Companies."



[Table] Net Trading Volume by Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing